Monocytes appear to be central to atherogenesis both as the progenitors of foam cells and as a potential source of growth factors mediating intimal hyperplasia, but the chemical messages which stimulate the influx of monocytes into human atheroma remain unknown. Monocyte chemoattractant protein-i (MCP-1) is a recently described molecule with powerful monocyte chemotactic activity expressed by monocytes, vascular endothelial cells, and smooth muscle cells in culture. To begin to address the role of MCP-1 in vivo, we examined 10 normal arteries and 14 diseased human arteries for MCP-1 expression by in situ hybridization. MCP-1 mRNA was detected in 16% of 10,768 cells counted in human carotid endarterectomy specimens with highest expression seen in organizing thrombi (33%) and in macrophage rich areas bordering the necrotic lipid core (24%) as compared to the fibrous cap (8%) and the necrotic lipid core itself (5%). Based on immunohistochemical staining of serial sections and on cell morphology, MCP-1 mRNA appeared to be expressed by vascular smooth muscle cells (VSMC), mesenchymal appearing intimal cells (MICs), and macrophages. By contrast, few cells expressing MCP-1 mRNA were found in normal arteries (< 0.1%). These data suggest a potential role for MCP-1 in mediating monocytic infiltration of the artery wall. (J.
Introduction
Monocyte-derived foam cells are a major component of atheroma, comprising as much as 60% of cells found in the necrotic lipid core, and 10-20% ofcells in the fibrous cap (1) . These cells have been demonstrated not only in mature plaques but also in early fatty streaks in animal models of atherogenesis and in human disease (2) . It has been suggested that growth factors produced by plaque macrophages may be important in terms of plaque progression (3) . The signals which attract monocytes Reprint requests should be addressed to Josiah N. Wilcox, Division of Hematology/Oncology, Emory University School of Medicine, 308 Woodruff Memorial Building, Drawer AR, Atlanta, GA 30322.
Receivedfor publication 8 November 1990 and in revisedform 16 April 1991. into these lesions remain unknown. Monocyte chemoattractant protein-l (MCP-1)I is a secreted molecule with potent chemotactic activity for monocytes (4) . MCP-l is expressed by cultured glioma cells (4) , fibroblasts (5), monocytes (6) , lymphocytes (7), endothelial cells (8) , and smooth muscle cells (9) .
TNFa (5, 8, 10) , IL-1j (5, 8, 10) , yIFN (8) , and endotoxin (5, 10 ) have all been shown to increase MCP-l mRNA levels in cultured endothelial cells and fibroblasts. In addition, increases in MCP-l-like activity and MCP-l mRNA have been documented in supernatants of human umbilical vein endothelial cells (HUVE's) stimulated with serum enriched with minimally oxidized LDL and ft VLDL (1 1, 12) . These in vitro studies suggest a potential role for MCP-l in the recruitment of monocytes into the vessel wall in the setting ofinflammation or hyperlipidemia.
To address whether MCP-l may play a role in recruiting monocytes to the vessel wall in vivo, we set out to identify MCP-l mRNA production in human atheroma using in situ hybridization. Atherosclerotic plaques exhibited marked hybridization, especially in macrophage-rich inflammatory regions. By comparison, minimal expression was noted in control arteries without atherosclerotic disease.
To identify possible regulators of MCP-1 production in cells derived from human atheroma, vascular smooth muscle cells (VSMCs) grown from human carotid endarterectomy specimens were stimulated with various cytokines and MCP-1 mRNA levels were determined by Northern blot. Tumor necrosis factor (TNFa), gamma interferon (yIFN), and supernatants from mixed lymphocyte culture were shown to stimulate production of MCP-l mRNA, whereas 10% FCS did not.
These data suggest a potential in vivo role for MCP-l in mediating monocytic infiltration of the artery wall, and a role for induction ofMCP-l expression by inflammatory mediators in modulating this process.
Methods
MCP-1 probe isolation. The cDNA for MCP-I was cloned from stimulated human lung fibroblasts using polymerase chain reaction (PCR) amplification of cDNA made from cytoplasmic RNA ,Vale%.
the Xho I and Eco RI sites of Bluescript SK-plasmid and its sequence determined by dideoxy nucleotide sequencing (16) . Primer sequences were 5' CCC CTC GAG TCC AGC ATG AAA GTC TCT GCC CTT  for the 5' sequence, and 5' CCC GAA TTC TGT TCA AGT CTT CGG  AGT TTG GGT for the 3' complementary sequence. In situ hybridization. Human carotid endarterectomy specimens were obtained directly from the operating room, fixed for 2 h at 4VC in 4% paraformaldehyde immediately upon surgical excision, cryopreserved in 15% sucrose for 3 h and frozen in OCT at -70'C. To construct riboprobes, Bluescript KS+ plasmid containing a full-length MCP-I insert was made linear by restriction digestion with Eco RI or Xho I (for sense and antisense probes, respectively), then transcribed using T3 or T7 RNA polymerase (Stratagene Corp., La Jolla, CA) in the presence of"S-UTP. In situ hybridization was performed on 10 Itm frozen histologic sections as previously described (17, 18) . After coating with photographic emulsion, sections were exposed for 4-12 wk. Exposed sections were counterstained with hematoxylin and eosin. The proportion of cells expressing MCP-1 was determined by counting 10,768 individual cells identified by nuclear staining at 400x in the 14 atherosclerotic specimens hybridized to the MCP-l riboprobe (Fig. 1, e (17, 18) . Counterstaining was done with 0.4% methyl green (Sigma Corp.).
Cell culture. VSMCs were cultured in collagen matrix (Vitrogen; Collagen Corp., Palo Alto, CA) from human atheroma obtained at carotid endarterectomy using published techniques (23) . Medium was changed twice weekly, and cells passed before reaching confluence. All cells were used within the first six passages.
Smooth muscle cell phenotype was confirmed by immunohistochemical staining using HHF35 and fluorescein secondary antibody. Cultured cells stained positive for actin in a spiculated pattern typical for smooth muscle cells in 83±5% (95% confidence interval) of 195 cells counted (not shown).
Northern blotting. VSMCs grown to 90% confluence in 150 cm2 flasks were made quiescent by incubating for 48 h with serum-free medium after washing 3x with PBS. Thereafter, they were either stimulated for 4 or 24 h with the cytokines or growth factors used in each specific experiment. Total cellular RNA was isolated using the guanidium isothiocyanate method (14) . 10 ug of glyoxal-treated RNA was then run in a 1% agarose gel and transfered to nylon reinforced nitrocellulose (Schleicher & Schuell Corp., Keene, NH) as described (14) .
32P-labeled MCP-l probe was produced using the random primer technique and T7 DNA polymerase (Stratagene Random Primer kit; Stratagene Corp., La Jolla, CA). Nitrocellulose membranes were prehybridized for 4 h and hybridized at 420 over night at a concentration of 106 cpm/ml in buffer containing 50% formamide. Two washes using 2X SSC with 0.1% SDS at 550 and two high-stringency washes using 0.1 x SSC with 0.1% SDS at 550 were performed for 15 min each. Nitrocellulose was then exposed to Kodak X-OMAT film with an intensifying screen at -70°for variable periods of time depending on estimated radioactivity of the nitrocellulose membranes.
Results
In situ hybridization. 14 carotid endarterectomy specimens, eight normal coronary arteries, and two normal internal mammary arteries were examined by in situ hybridization. Positive hybridization for MCP-l was clearly present in all atheroma examined ( Fig. 1 , a, c, e). No cellular hybridization was seen in control slides probed with MCP-l sense riboprobe (data not shown).
Expression of MCP-I in histologically defined regions of human atheroma. Positive hybridization was detected in 16% of 10,768 cells counted. Random high-power fields among representative histologic regions were scored using a counting grid (8- (g) Section of normal internal mammary artery obtained from coronary bypass surgical specimens hybridized with MCP-I antisense probe. Very low levels of hybridization were seen in normal vessels. Examination ofthis section under high power revealed only four cells hybridizing to MCP-l probe (arrows). The other bright areas in the adventitia represent refractile fibrous tissue, a normal feature of the adventitia when viewed by epiluminescence (8-wk exposure; magnification, 100). (h) Section of control coronary artery obtained from cardiomyopathy patient during heart transplantation (native heart) hybridized with MCP-l antisense probe. Hybridization was rare in these specimens. One smooth muscle-appearing cell can be seen in the media with higher than background hybridization (arrow). Concentric fibrous intimal thickening was a universal finding in adult coronary specimens, however, it was not associated with hybridization of probe (8-wk exposure; magnification, 125). .0 4s (Fig. 1, e and f) . Significantly more MCP-1-positive cells were found in areas of the fibrous cap regions predominantly containing cells with pleomorphic nuclei arranged in a random orientation (10% of2,871 cells) compared with fibrous cap regions containing predominantly uniform spindle shaped cells typical of VSMCs (5% of 1,471 cells, P < 0.001, chi square). The in situ signal intensity was generally lower over cells in the fibrous cap compared with the intense signals seen in the same sections most notably in inflammatory areas bordering the necrotic lipid core (see below).
Regions of the fibrous cap with uniform spindle-shaped cells generally showed uniform staining with the HHF35 antibody. Fibrous cap regions with pleomorphic nuclei often exhibited fewer VSMCs staining with HHF35 and frequently contained HAM56 and a few UCHLl-positive cells as well. MCP-1-positive cells in the fibrous cap included a population of mesenchymal appearing intimal cells (MIC) often in pleomorphic zones which did not co-stain with any of the antibodies used in this study (Fig. 2) . These cells had large pale nuclei distinct from the typical spindle-shaped smooth muscle cell nucleus, a stellate cytoplasm, and were morphologically similar to the platelet-derived growth factor (17) or tissue factor (18) mRNA-containing MICs described previously in atherosclerotic plaques. Many areas within the atherosclerotic plaques examined contained numerous cells meeting these criteria especially in the pleomorphic regions ofthe fibrous cap and areas of organizing thrombi. It is difficult to estimate the proportion of positive MICs because their detection is by a process of exclusion rather than direct identification.
Organizing thrombus. Many cells hybridized strongly to the MCP-l probe in areas of focal organizing thrombi (33% of 1,035 cells; Fig. 1, a and b) . These regions often contained many HAM56-positive cells with some UCHLl-positive T cells. Spatial correlation of HAM56-positive cells and cells hybridizing for MCP-l strongly suggests that macrophages express MCP-1. We cannot exclude the possibility that some expression in these areas is by MICs because these cells are often found in areas of focal organizing thrombus (24, 25) .
Necrotic lipid core. Discrete cells in the necrotic lipid core were markedly positive for MCP-1 mRNA (6% of 475 cells) and were often adjacent to nonhybridizing cells. The necrotic cores exhibited diminished cellular density and contained predominantly necrotic debris, foam cell deposits, cholesterol clefts, and calcification. In agreement with previous studies macrophages were the predominant cell type found in the necrotic core although UCHLl-positive cells were also identified in these regions (1 Expression ofMCP-J by cell type. To identify specific cell types associated with MCP-l production, serial microscopic sections immediately adjacent to sections hybridized with the MCP-1 probe were used for immunohistochemical staining with HAM56, UCHL1, HHF35, and Ulexlectin in three representative specimens. Carefully chosen regions which stained exclusively with HAM56 were found to be strongly positive for MCP-1 (38% of 1,754 cells) . Cells meeting histologic criteria for macrophages, including large pale nucei with foamy cytoplasm, clearly hybridized with MCP-1 riboprobe, whereas hemosiderin containing macrophages did not. Fewer MCP-l positive cells were found in regions staining exclusively with HHF35 (5% of 1,163 cells). These areas showed no HAM56 staining. Despite the low percentage of cells hybridizing in these areas, individual cells clearly meeting histologic criteria for VSMCs, including spindle-shaped nuclei and elongated cytoplasm, hybridized for MCP-l (Fig. 1, e andf) . It is not possible to comment on the colocalization of T cell staining with MCP-l hybridization because no region was found to stain exclusively with UCHL1 in the absence of HAM56 staining. These data suggest that both VSMCs and macrophages can express MCP-l in vivo. In addition, cells not staining with HAM56 or HHF35, meeting the histological criteria for MICs were also seen to hybridize strongly for MCP-1.
We failed to detect MCP-l hybridization to endothelial cells lining the vasa vasorum or on the lumenal surface of the plaques. Given the fact that the total amount of endothelium seen in these specimens was small due to transverse sectioning, lack ofendothelium in portions ofthe plaque and in some cases loss of endothelium in preparation, conclusions regarding MCP-l expressed by the endothelium in vivo cannot be drawn from this study.
Normal, nondiseased internal mammary artery specimens obtained from coronary bypass operations exhibited little production of MCP-l mRNA as determined by in situ hybridization. Hybridizing cells, if present, tended to be found in the adventitia (Fig. 1 g) . Occasional macrophage staining was seen in the adventitia suggesting that hybridizing cells may be scattered tissue macrophages. Like the internal mammary arteries, normal coronary vessels obtained from explanted hearts also showed only minimal MCP-I expression (Fig. 1 h) . These specimens were obtained from nonatherosclerotic coronary arteries in patients with idiopathic cardiomyopathies undergoing heart transplantation. A small amount of concentric intimal thickening which was invariably present in these specimens but no advanced atherosclerotic lesions were seen. Hybridization was found in < 0.1% of cells counted in normal vessels.
Cytokine stimulation ofVSMCs in culture. The the responses to cytokines seen in the presence or absence of fetal calf serum.
Discussion
Human monocyte chemoattractant protein-l1 (MCP-1) is a secreted peptide which exhibits powerful monocyte chemoattractant properties at nanomolar concentration. It has been detected in smooth muscle cells, endothelium, stimulated monocytes, lymphocytes, fibroblasts, and various tumor cell lines (6) . Because the signals which attract monocytes to the atherosclerotic plaque remain unknown, we examined arteries for MCP-l production in vivo. We have shown that there is easily detectable MCP-l expression by multiple cell types in various regions of the atherosclerotic plaque, but little expression in normal vessels.
The majority of MCP-1 production was seen in macrophages. MCP-1 was noted in all regions ofthe plaque with high concentrations of macrophages, especially underlying necrotic lipid cores and in organizing thrombi. The production ofMCP-1 by macrophages may represent an amplification mechanism for the recruitment ofadditional macrophages to the atherosclerotic plaque.
In contrast to macrophages, VSMCs less frequently hybridized with MCP-l probe. Individual VSMCs that hybridized strongly were sometimes surrounded by nonexpressing cells. Expression in these cells was not dependent on the proximity of tissue macrophages; hybridizing VSMCs were found in areas both with and without HAM56 staining. Because signals which stimulate MCP-l production in VSMCs are not known and because MCP-l production by VSMCs may be involved in the initial recruitment of macrophages to the vessel wall, we exposed cultured atheroma-derived VSMCs TNFa and yIFN, then determined MCP-I mRNA levels by Northern blot. The increase in MCP-1 expression induced by yIFN and supernatants of mixed lymphocyte culture suggest a possible role for activated T lymphocytes in stimulation of vascular smooth muscle MCP-l production.
The production of MCP-1 by MICs adds to the increasing evidence suggesting that these cells secrete a number of bioactive factors (17, 18) . The origin ofMICs and their role in atherogenesis remain unknown.
The identification ofVSMCs and MICs as sources ofMCP-1 in atherosclerotic plaque suggests that this molecule may potentially play a role in monocyte infiltration in the early development of the plaque. Mediators stimulating monocyte infiltration into early fatty streaks are unknown, but these lesions have been identified as possible precursors to mature atherosclerotic plaques (3). It is tempting to speculate that MCP-l production by VSMCs or MICs may be elicited by lipoproteins ( 11) or other stimuli in early atherosclerotic lesions. With infiltration of monocytes, a positive feedback mechanism might exist whereby infiltrating monocyte/macrophages secrete MCP-1 in large amounts, thereby attracting more peripheral blood monocytes to the developing atherosclerotic plaque. Antagonists ofMCP-1 action will be needed to evaluate any causal role for MCP-I in vivo.
In summary, we have shown that MCP-l mRNA is expressed in atherosclerotic plaques in vivo. To our knowledge, this is the first study to demonstrate the production ofa specific monocyte chemotactic agent in human atheroma.
